You have 9 free searches left this month | for more free features.

City

Beijing (1)

Shanghai (1)

Condition

Head and Neck Squamous Carcinoma (1)

Hepatocellular Carcinoma (1)

Overall Status

Recruiting (2)

Sign in for free

Phase

phase 1 (1)

phase 2/phase 3 (1)

Sponsor

Sinocelltech Ltd. (2)

Collaborator

Intervention

sct-i10a (2)

docetaxel (1)

paclitaxel (1)

sct200 (1)

sct510 (1)

sorafenib 200mg (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

sct-i10a

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Head and Neck Squamous Carcinoma Trial in Shanghai (SCT-I10A, SCT200, paclitaxel)

Recruiting

Head and Neck Squamous Carcinoma

SCT-I10A
+3 more

Shanghai, China

Shanghai East Hospital

Sep 22, 2022

Hepatocellular Carcinoma Trial in Beijing (SCT-I10A, SCT510, Sorafenib 200mg)

Recruiting

Hepatocellular Carcinoma

SCT-I10A
+2 more

Beijing, Beijing, China

307 Hospital of PLA

Nov 11, 2020